Greco A - Search Results

1

The M581V mutation, associated with a mild form of congenital insensitivity to pain with anhidrosis, causes partial inactivation of the NTRK1 receptor.

Miranda C, Selleri S, Pierotti MA, Greco A. Miranda C, et al. Among authors: greco a. J Invest Dermatol. 2002 Oct;119(4):978-9. doi: 10.1046/j.1523-1747.2002.00140.x. J Invest Dermatol. 2002. PMID: 12406349 Free article. No abstract available.

2

Novel pathogenic mechanisms of congenital insensitivity to pain with anhidrosis genetic disorder unveiled by functional analysis of neurotrophic tyrosine receptor kinase type 1/nerve growth factor receptor mutations.

Miranda C, Di Virgilio M, Selleri S, Zanotti G, Pagliardini S, Pierotti MA, Greco A. Miranda C, et al. Among authors: greco a. J Biol Chem. 2002 Feb 22;277(8):6455-62. doi: 10.1074/jbc.M110016200. Epub 2001 Nov 21. J Biol Chem. 2002. PMID: 11719521 Free article.

3

Oncogenic rearrangements of the NTRK1/NGF receptor.

Pierotti MA, Greco A. Pierotti MA, et al. Among authors: greco a. Cancer Lett. 2006 Jan 28;232(1):90-8. doi: 10.1016/j.canlet.2005.07.043. Epub 2005 Oct 20. Cancer Lett. 2006. PMID: 16242838 Review.

4

Gain of function mutations of RTK conserved residues display differential effects on NTRK1 kinase activity.

Miranda C, Zanotti G, Pagliardini S, Ponzetto C, Pierotti MA, Greco A. Miranda C, et al. Among authors: greco a. Oncogene. 2002 Nov 28;21(54):8334-9. doi: 10.1038/sj.onc.1206052. Oncogene. 2002. PMID: 12447696

5

Functional characterization of NTRK1 mutations identified in melanoma.

Miranda C, Mazzoni M, Sensi M, Pierotti MA, Greco A. Miranda C, et al. Among authors: greco a. Genes Chromosomes Cancer. 2014 Oct;53(10):875-80. doi: 10.1002/gcc.22200. Epub 2014 Jun 26. Genes Chromosomes Cancer. 2014. PMID: 24965840

6

The signaling adapters fibroblast growth factor receptor substrate 2 and 3 are activated by the thyroid TRK oncoproteins.

Ranzi V, Meakin SO, Miranda C, Mondellini P, Pierotti MA, Greco A. Ranzi V, et al. Among authors: greco a. Endocrinology. 2003 Mar;144(3):922-8. doi: 10.1210/en.2002-221002. Endocrinology. 2003. PMID: 12586769

7

Analysis of SHP-1-mediated down-regulation of the TRK-T3 oncoprotein identifies Trk-fused gene (TFG) as a novel SHP-1-interacting protein.

Roccato E, Miranda C, Raho G, Pagliardini S, Pierotti MA, Greco A. Roccato E, et al. Among authors: greco a. J Biol Chem. 2005 Feb 4;280(5):3382-9. doi: 10.1074/jbc.M407522200. Epub 2004 Nov 22. J Biol Chem. 2005. PMID: 15557341 Free article.

8

TRK oncogenes in papillary thyroid carcinoma.

Greco A, Roccato E, Pierotti MA. Greco A, et al. Cancer Treat Res. 2004;122:207-19. doi: 10.1007/1-4020-8107-3_12. Cancer Treat Res. 2004. PMID: 16209047 Review. No abstract available.

9

Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activation.

Roccato E, Pagliardini S, Cleris L, Canevari S, Formelli F, Pierotti MA, Greco A. Roccato E, et al. Among authors: greco a. Oncogene. 2003 Feb 13;22(6):807-18. doi: 10.1038/sj.onc.1206189. Oncogene. 2003. PMID: 12584559

10

Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer.

Frattini M, Ferrario C, Bressan P, Balestra D, De Cecco L, Mondellini P, Bongarzone I, Collini P, Gariboldi M, Pilotti S, Pierotti MA, Greco A. Frattini M, et al. Among authors: greco a. Oncogene. 2004 Sep 23;23(44):7436-40. doi: 10.1038/sj.onc.1207980. Oncogene. 2004. PMID: 15273715

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,075 results

Search Page

Filters